Keld Danø

Overview

Best Publications

• Plasminogen activators, tissue degradation, and cancer.

  K Danø;P A Andreasen;J Grøndahl-Hansen;P Kristensen

  3984
  Citations

• Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells.

  Keld Danø

  1017
  Citations

• Impaired wound healing in mice with a disrupted plasminogen gene.

  J Romer;T H Bugge;T H Bugge;C Pyke;L R Lund

  819
  Citations

• Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.

  Ann L. Roldan;Maria Vittoria Cubellis;Maria Teresa Masucci;Niels Behrendt

  781
  Citations

• Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.

  M Ploug;E Rønne;N Behrendt;A L Jensen

  759
  Citations

• Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways.

  Leif R. Lund;John Rømer;Nicole Thomasset;Helene Solberg

  753
  Citations

• Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor.

  V Ellis;N Behrendt;K Danø

  625
  Citations

• Laminin-5 Is a Marker of Invading Cancer Cells in Some Human Carcinomas and Is Coexpressed with the Receptor for Urokinase Plasminogen Activator in Budding Cancer Cells in Colon Adenocarcinomas

  Charles Pyke;Sirpa Salo;Elisabeth Ralfkiær;John Rømer

  569
  Citations

• Plasminogen activation and cancer

  Keld Danø;Niels Behrendt;Gunilla Høyer-Hansen;Morten Johnsen

  564
  Citations

• Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation

  Morten Johnsen;Leif R Lund;John Rømer;Kasper Almholt

  516
  Citations

• High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.

  Jan Grøndahl-Hansen;Ib Jarle Christensen;Christian Rosenquist;Nils Brünner

  512
  Citations

• Localization of Messenger RNA for Mr 72,000 and 92,000 Type IV Collagenases in Human Skin Cancers by in Situ Hybridization

  Charles Pyke;Elisabeth Ralfkiær;Piricko Huhtala;Tina Hurskainen

  469
  Citations

• cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

  D Ginsburg;R Zeheb;A Y Yang;U M Rafferty

  445
  Citations

• Prognostic Impact of Urokinase, Urokinase Receptor, and Type 1 Plasminogen Activator Inhibitor in Squamous and Large Cell Lung Cancer Tissue

  Helle Pedersen;Nils Brünner;Dorthe Francis;Kell Østerlind

  435
  Citations

• The Plasminogen Activator Inhibitor PAI-1 Controls In Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin: Implications for Antiangiogenic Strategies

  Khalid Bajou;Véronique Masson;Robert D. Gerard;Petra M. Schmitt

  418
  Citations

• Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells

  J Pöllänen;O Saksela;EM Salonen;P Andreasen

  410
  Citations

• Cancer invasion and tissue remodeling--cooperation of protease systems and cell types.

  Keld Danø;John Rømer;Boye S. Nielsen;Signe Bjørn

  383
  Citations

• Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.

  Thomas H. Bugge;Matthew J. Flick;Mary Jo S. Danton;Cynthia C. Daugherty

  376
  Citations

• The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants.

  N Behrendt;E Rønne;M Ploug;T Petri

  366
  Citations

• A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification.

  Lars Søegaard Nielsen;G M Kellerman;N Behrendt;R Picone

  365
  Citations